<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00275977</url>
  </required_header>
  <id_info>
    <org_study_id>020</org_study_id>
    <nct_id>NCT00275977</nct_id>
  </id_info>
  <brief_title>Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells</brief_title>
  <official_title>Treatment of Myocardial Infarction With Autologous Bone Marrow Derived Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate whether infusion of autologous bone marrow derived
      stem cells can improve cardiac function in the aftermath of a myocardial infarction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary coronary intervention within a few hours of a myocardial infarction has greatly
      reduced mortality as well as the risk of developing chronic heart failure. There are though
      still a large number of patients that develop symptoms of heart failure in the form of
      fatigue and breathlessness with physical exertion in spite of medical treatment. With the
      advance in stem cell technology there is now hope for the possibility of
      regenerating/repairing dead myocardial tissue, hence improving cardiac function.

      The current study is a pilot study that is going to precede a later double blinded randomized
      study. The aim of the study is to evaluate patient safety, optimize procedures, and to be
      used in power calculation in the design of the following study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2006</start_date>
  <completion_date>March 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in left ventricular funtion at 4 months followup using contrast enhanced echocardiography</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary catherization and stem cell infusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chestpain

          -  Troponin T, &gt; 0,1ng/ml

          -  Succesfull revascularization of culprit lesion with PCI.

          -  No more than stenosis of 2 major epicardiel coronary arteries.

        Exclusion Criteria:

          -  Cardiogenic shock

          -  Known LVEF&lt;45%

          -  Cardiomyopathy

          -  Atrialfibrillation or fluctuation

          -  Takyarytmia

          -  Infection

          -  Chronic inflammatory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moustapha Kassem, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of endocrinology M, Odense University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Malthe AM Kristiansen, MD</last_name>
    <phone>+45 65504081</phone>
    <email>mkristiansen@health.sdu.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of endocrinology M, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Malthe AM Kristiansen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moustapha Kassem, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004 Jul 10-16;364(9429):141-8.</citation>
    <PMID>15246726</PMID>
  </reference>
  <reference>
    <citation>Sch√§chinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004 Oct 19;44(8):1690-9.</citation>
    <PMID>15489105</PMID>
  </reference>
  <verification_date>January 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2006</study_first_submitted>
  <study_first_submitted_qc>January 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2006</study_first_posted>
  <last_update_submitted>July 22, 2010</last_update_submitted>
  <last_update_submitted_qc>July 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2010</last_update_posted>
  <keyword>&quot;Stem cell&quot;</keyword>
  <keyword>&quot;autologous bone marrow transplantation&quot;</keyword>
  <keyword>&quot;Myocardial infarction&quot;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

